权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Tracing Spread of Pathology Within The HD Brain via Automated Neuroimaging

通过自动神经影像追踪 HD 大脑内病理学的传播

基本信息

批准号：
10155594
负责人：
MICHAEL I MILLER
金额：
$ 59.91万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-06-15 至 2023-04-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10155594
关键词：
Age Alzheimer&apos s Disease Amygdaloid structure Antisense Oligonucleotides Atrophic Axon Blood - brain barrier anatomy Brain Brain Diseases Brain region CAG repeat Cell Nucleus Cells Cerebral cortex Clinical Clinical Trials Code Cognition Disorders Cognitive Corpus striatum structure Data Development Diagnosis Disease Progression Emotional Emotional disorder Exposure to Gender Gene Silencing Genes Genetic Hippocampus (Brain)Huntington Disease Huntington gene Huntington protein Image Intervention Intervention Trial Methods Modeling Motor Movement Mutation Nerve Degeneration Neurodegenerative Disorders Neurons Outcome Parkinson Disease Pathogenesis Pathologic Pathology Pattern Prion Diseases Proteins RNA Reagent Scanning Shapes Stretching Structure Testing Thalamic structure Time Toxic effect automated analysis base case control cerebral atrophy clinical outcome measures clinically significant cognitive change design excitotoxicity gray matter innovation longitudinal analysis magnetic resonance imaging biomarker mind control mutant neuroimaging polyglutamine prion-like regional atrophy shape analysis small hairpin RNA spatiotemporal success white matter

项目摘要

TRACING SPREAD OF PATHOLOGY WITHIN THE HD BRAIN VIA AUTOMATED NEUROIMAGING Huntington's disease (HD) is a progressive fatal neurodegenerative disorder caused by an expanding CAG repeat in the Huntingtin gene coding for an expanding polyglutamine stretch in the Huntingtin protein. Neurodegeneration in HD is in large part caused by toxic effects of the abnormal Htt protein, and there is increasing evidence that mutant Htt can spread, like prions, and like abnormal proteins in other neurodegenerative diseases, from one neuron to another. Elucidating the sequence and pattern of atrophy in the HD brain is of special current importance, with “gene silencing” or “RNA-lowering” trials, using antisense oligonucleotides, or shRNA, or related reagents, in active development. The key to success of these trials will be to know where and when to intervene, since these reagents do not penetrate the blood-brain-barrier, and must be injected into the CNS. Our studies will elucidate the temporal and spatial patterns of the spread of HD neurodegeneration, to elucidate the pathogenesis of HD and to help guide interventional trials. In Specific Aim 1, we will conduct cross sectional and longitudinal analyses of the spatial and temporal pattern of volumetric change and shape change in subregions of HD compared to control brains, using longitudinal T1 and DTI scans from HD cases and controls from the PREDICT-HD study and the TRACK-HD study. Scans will undergo automated processing through MRICloud, segmented into about 400 subregions. We hypothesize that atrophy will begin in the striatum and spread sequentially to adjacent white matter and then to cortical gray matter. Alternatively degeneration may be multifocal. In Specific Aim 2 we will determine clinical correlations of the brain atrophy from Aim 1. In Specific Aim 3 we will use tract-tracing methods to study the spread of pathology in the HD brain. We hypothesize that the spread of atrophy in the HD brain follows patterns of axonal connectivity. Alternatively, it is possible that pathology begins and spreads in a multifocal fashion. Taken together these studies will delineate the longitudinal spread of pathology within the HD brain, and its clinical consequences. This information will elucidate the pathogenesis of HD and will be critical for designing the timing and localization of planned interventional trials.

通过自动神经成像追踪HD脑内的病理传播亨廷顿病(HD)是一种进行性的致命性神经退行性疾病，由不断扩大的CAG引起在亨廷顿蛋白中重复编码一个扩展的聚谷氨酰胺延伸的亨廷顿基因。 HD的神经变性在很大程度上是由异常的Htt蛋白的毒性作用引起的，并且有越来越多的证据表明，突变的Htt可以像Pron一样传播，也像其他神经退行性疾病，从一个神经元到另一个神经元。阐明脑萎缩的顺序和模式 HD大脑在当前具有特殊的重要性，使用反义技术进行“基因沉默”或“RNA降低”试验正在积极开发的寡核苷酸或shRNA或相关试剂。这些试验成功的关键是要知道何时何地干预，因为这些试剂不能穿透血脑屏障，而且必须注射到中枢神经系统。我们的研究将阐明HD传播的时间和空间模式神经变性，阐明HD的发病机制，并帮助指导介入试验。以特定的目标 1、我们将对体积的时空格局进行横断面和纵向分析利用纵向T1和DTI，与对照组相比，HD亚区的变化和形状变化扫描来自HD病例和来自Forecast-HD研究和Track-HD研究的对照组。扫描将通过MRICout进行自动化处理，将其分割成大约400个子区域。我们假设这种萎缩将开始于纹状体，然后依次扩散到邻近的白质，然后扩散到皮质灰质。物质。或者，退变可以是多灶性的。在特定的目标2中，我们将确定临床相关性在特定的目标3中，我们将使用轨迹追踪的方法来研究脑萎缩的扩散。高清大脑的病理学。我们假设HD脑萎缩的扩散遵循以下模式轴突连接。或者，病理也有可能以多焦点的方式开始和传播。综上所述，这些研究将勾勒出病理在HD大脑中的纵向扩散，以及其临床后果。这些信息将阐明HD的发病机制，并将对设计至关重要计划中的介入试验的时机和本地化。

项目成果

期刊论文数量（3）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington's disease.

DOI：
10.1016/j.nicl.2023.103493
发表时间：
2023
期刊：
NEUROIMAGE-CLINICAL
影响因子：
4.2
作者：
Hu, Beini;Younes, Laurent;Bu, Xuan;Liu, Chin-Fu;Ratnanather, J. Tilak;Paulsen, Jane;Georgiou-Karistianis, Nellie;Miller, Michael I.;Ross, Christopher;Faria, Andreia, V
通讯作者：
Faria, Andreia, V

Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington's disease.

纵向成像突出显示亨廷顿病中优先出现的基底神经节环路萎缩。